caffeic acid phenethyl ester has been researched along with rosmarinic acid in 4 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (rosmarinic acid) | Trials (rosmarinic acid) | Recent Studies (post-2010) (rosmarinic acid) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 1,174 | 15 | 877 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | rosmarinic acid (IC50) |
|---|---|---|---|
| Mcl-1 | Homo sapiens (human) | 2.0257 | |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | Mycobacterium tuberculosis H37Rv | 84.94 | |
| Interstitial collagenase | Homo sapiens (human) | 5.6 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.45 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.86 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 3.91 | |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | 3.72 | |
| Alpha-synuclein | Homo sapiens (human) | 0.21 | |
| Integrase | Human immunodeficiency virus 1 | 5.6375 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Kosaka, Y; Mizuguchi, M; Yokoyama, T | 1 |
| Endo, Y; Hatayama, K; Hayashi, T; Nakano, H; Ohta, K; Sato, D; Sato, Y; Seki, C; Taguchi, R; Takahashi, T; Tokuraku, K; Uwai, K | 1 |
4 other study(ies) available for caffeic acid phenethyl ester and rosmarinic acid
| Article | Year |
|---|---|
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
Topics: Amyloid Neuropathies, Familial; Amyloidosis; Caffeic Acids; Coumaric Acids; Masoprocol; Phenylethyl Alcohol; Prealbumin; Propolis | 2014 |
Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
Topics: Amyloid beta-Peptides; Antioxidants; Cinnamates; Depsides; Dose-Response Relationship, Drug; Humans; Molecular Dynamics Simulation; Molecular Structure; Protein Aggregates; Rosmarinic Acid; Structure-Activity Relationship | 2017 |